chinese glp 1 Innovent's weight-loss drug highlights China challenge for Novo, Lilly China patent expiry and new

Medical weight loss programs are one of the most effective and sustainable ways to help patients return to a healthy weight, significantly reducing their risks of developing weight-related health conditions

These costs could instead be redirected to deliver new, increasingly effective treatments like GLP-1RAs to those most in need, reducing the burden of substance abuse for communities across the country.

Understanding available medication variantsinjectable semaglutide, oral semaglutide, tirzepatide, and dual-receptor compoundsis essential because individual response varies based on metabolic factors, genetic predispositions, and prior treatment history

Clients' and coaches' perspectives of a life coaching intervention for parents with overweight/obesity

Sleep 1996